TY  JOUR
TI  USE OF INHIBITORS  OF TYPE 2 SODIUM-GLUCOSE COTRANSPORTER  FOR THE CARDIOPROTECTION  IN THE PATIENTS UNDERGOING POTENTIALLY TOXIC ANTI-TUMOR THERAPY. REVIEW OF LITERATURE
KW  anthracyclines
KW  inhibitors of type 2 sodium-glucose cotransporter (SGLT2i)
KW  cardiac oncology
KW  cardiac protection
KW  cardiotoxicity
KW  anti-tumor therapy
JO  Medical Bulletin of the Ministry of Internal Affairs
AU  Salukhov, V.V.
AU  PUZhALOV, I.A.
AU  SANTAKOV, A.A.
AU  VARAVIN, N.A.
PY  2025
IS  2025
PB  State institution Joint editorial office of the Ministry of Internal Affairs of Russia